{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:20:14Z","timestamp":1789885214422,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["602437"],"award-info":[{"award-number":["602437"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.vaccine.2017.12.053","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T10:28:07Z","timestamp":1514975287000},"page":"873-880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles"],"prefix":"10.1016","volume":"36","author":[{"given":"Alejandro","family":"Ramirez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Maucourant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"D'Ascanio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Crescente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Na","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Farinelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude P.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.12.053_b0005","unstructured":"Centers for Disease C, Prevention. Update: influenza activity\u2013United States and worldwide, 1993. MMWR Morb Mortal Wkly Rep. 1993;42:752\u20135."},{"key":"10.1016\/j.vaccine.2017.12.053_b0010","unstructured":"Centers for Disease C, Prevention. Update: influenza activity\u2013United States and worldwide, and composition of the 1993-94 influenza vaccine. MMWR Morb Mortal Wkly Rep. 1993;42:177\u201380."},{"key":"10.1016\/j.vaccine.2017.12.053_b0015","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.vaccine.2015.12.003","article-title":"Trends in U.S. hospitalizations and inpatient deaths from pneumonia and influenza, 1996\u20132011","volume":"34","author":"Chang","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.12.053_b0020","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJMra1208802","article-title":"Pandemic preparedness and response\u2013lessons from the H1N1 influenza of 2009","volume":"370","author":"Fineberg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.12.053_b0025","doi-asserted-by":"crossref","first-page":"15279","DOI":"10.1038\/srep15279","article-title":"H3N2 mismatch of 2014\u201315 northern hemisphere influenza vaccines and head-to-head comparison between human and ferret antisera derived antigenic maps","volume":"5","author":"Xie","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2017.12.053_b0030","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1073\/pnas.162366899","article-title":"The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic","volume":"99","author":"Kilbourne","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2017.12.053_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0929-6646(09)60102-9","article-title":"Influenza pandemics: past, present and future","volume":"105","author":"Hsieh","year":"2006","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.vaccine.2017.12.053_b0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5694\/j.1326-5377.2009.tb02674.x","article-title":"A pandemic that's not bird flu? Pigs might fly","volume":"191","author":"Senanayake","year":"2009","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2017.12.053_b0045","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2017.12.053_b0050","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.12.053_b0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.antiviral.2013.01.010","article-title":"Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge","volume":"98","author":"Gao","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2017.12.053_b0060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fimmu.2011.00076","article-title":"Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design","volume":"2","author":"Kaminski","year":"2011","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2017.12.053_b0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.virusres.2011.09.037","article-title":"Novel vaccines against influenza viruses","volume":"162","author":"Kang","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2017.12.053_b0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-med-120611-145115","article-title":"Toward a universal influenza virus vaccine: prospects and challenges","volume":"64","author":"Pica","year":"2013","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.vaccine.2017.12.053_b0075","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.12.053_b0080","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/j.vaccine.2015.04.073","article-title":"Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e","volume":"33","author":"Tsybalova","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.12.053_b0085","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1016\/j.vaccine.2015.05.038","article-title":"Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses","volume":"33","author":"Wohlbold","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.12.053_b0090","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1016\/j.vaccine.2016.11.026","article-title":"Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses","volume":"34","author":"Zheng","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.12.053_b0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2017.01.010","article-title":"A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk","volume":"140","author":"Yang","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2017.12.053_b0100","doi-asserted-by":"crossref","first-page":"e0120751","DOI":"10.1371\/journal.pone.0120751","article-title":"Tandem fusion of hepatitis B core antigen allows assembly of virus-like particles in bacteria and plants with enhanced capacity to accommodate foreign proteins","volume":"10","author":"Peyret","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.12.053_b0105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.virol.2012.09.014","article-title":"A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles","volume":"435","author":"Blokhina","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.12.053_b0110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000050037","article-title":"HBV core particles as a carrier for B cell\/T cell epitopes","volume":"44","author":"Pumpens","year":"2001","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2017.12.053_b0115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/erv.12.150","article-title":"Hepatitis B core-based virus-like particles to present heterologous epitopes","volume":"12","author":"Roose","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.12.053_b0120","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/prot.24317","article-title":"In vitro and in vivo characterization of designed immunogens derived from the CD-helix of the stem of influenza hemagglutinin","volume":"81","author":"Mallajosyula","year":"2013","journal-title":"Proteins"},{"key":"10.1016\/j.vaccine.2017.12.053_b0125","first-page":"901817","article-title":"Protection against multiple subtypes of influenza viruses by virus-like particle vaccines based on a hemagglutinin conserved epitope","volume":"2015","author":"Chen","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2017.12.053_b0130","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1016\/j.vaccine.2006.05.082","article-title":"Improved design and intranasal delivery of an M2e-based human influenza A vaccine","volume":"24","author":"De Filette","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.12.053_b0135","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1016\/j.vaccine.2008.09.038","article-title":"Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies","volume":"26","author":"De Filette","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.12.053_b0140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.virol.2005.04.004","article-title":"Universal influenza A vaccine: optimization of M2-based constructs","volume":"337","author":"De Filette","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.12.053_b0145","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3201\/eid1703.100851","article-title":"Swine influenza virus antibodies in humans, western Europe, 2009","volume":"17","author":"Gerloff","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.12.053_b0150","unstructured":"Whelan MA, RAMIREZ CA, CRESENTE V. Vaccines based on hepatitis b core antigens; 2016. Patent application PCT\/GB2015\/053699 Publication# WO2016087863 A1 (Direct Link: https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf;jsessionid=A6D09D878DC3287B34FB0FF0F94BBB9D.wapp2nC?docId=WO2016087863&recNum=1&maxRec=&office=&prevFilter=&sortOption=&queryString=&tab=PCTDescription)."},{"key":"10.1016\/j.vaccine.2017.12.053_b0155","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints12","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.12.053_b0160","series-title":"Virology methods manual","first-page":"25","article-title":"2 \u2013 Virus isolation and quantitation A2 \u2013 Mahy, Brian WJ","author":"Hierholzer","year":"1996"},{"key":"10.1016\/j.vaccine.2017.12.053_b0165","doi-asserted-by":"crossref","first-page":"e59081","DOI":"10.1371\/journal.pone.0059081","article-title":"M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A","volume":"8","author":"Ibanez","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.12.053_b0170","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.vaccine.2015.04.066","volume":"33","author":"Ravin","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.12.053_b0175","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nrmicro2613","article-title":"Influenza A viruses: new research developments","volume":"9","author":"Medina","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2017.12.053_b0180","doi-asserted-by":"crossref","first-page":"18979","DOI":"10.1073\/pnas.1013387107","article-title":"Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2017.12.053_b0185","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.12.053_b0190","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.12.053_b0195","doi-asserted-by":"crossref","first-page":"546274","DOI":"10.1155\/2014\/546274","article-title":"Protective immunity based on the conserved hemagglutinin stalk domain and its prospects for universal influenza vaccine development","volume":"2014","author":"Khanna","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2017.12.053_b0200","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5582\/bst.2015.01060","article-title":"High copy numbers and N terminal insertion position of influenza A M2E fused with hepatitis B core antigen enhanced immunogenicity","volume":"9","author":"Sun","year":"2015","journal-title":"Biosci Trends"},{"key":"10.1016\/j.vaccine.2017.12.053_b0205","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/jvi.64.3.1375-1377.1990","article-title":"Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice","volume":"64","author":"Treanor","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.12.053_b0210","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2008.06.002","article-title":"Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein","volume":"80","author":"Wang","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2017.12.053_b0215","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.12.053_b0220","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01624-16","article-title":"Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner","volume":"7","author":"Mullarkey","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2017.12.053_b0225","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17318145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17318145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:23:41Z","timestamp":1759400621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17318145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0264410X17318145"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}